Showing results (21-30 of 1,815) with videos related to
Sort By:
Pageof 182
JCO Clinical Cancer Informatics|January 13, 2021
BOIN Suite: A Software Platform to Design and Implement Novel Early-Phase Clinical TrialsYanhong Zhou, Ruitao Lin, Ying-Wei Kuo, et al.The Annals of Applied Statistics|November 4, 2022
BAYESIAN HIERARCHICAL RANDOM-EFFECTS META-ANALYSIS AND DESIGN OF PHASE I CLINICAL TRIALSRuitao Lin, Haolun Shi, Guosheng Yin, et al.Biometrics|June 6, 2018
Bayesian optimal interval design with multiple toxicity constraintsRuitao LinStatistics in Medicine|January 31, 2022
TITE-BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacyYanhong Zhou, Ruitao Lin, J Jack Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Novel Clinical Trial Designs with Dose Optimization to Improve Long-term OutcomesPeter F Thall, Yong Zang, Andrew G Chapple, et al.Contemporary Clinical Trials|July 28, 2015
Bayes factor and posterior probability: Complementary statistical evidence to p-valueRuitao Lin, Guosheng YinStatistics in Medicine|August 9, 2017
STEIN: A simple toxicity and efficacy interval design for seamless phase I/II clinical trialsRuitao Lin, Guosheng YinStatistical Methods in Medical Research|July 17, 2015
Bayesian optimal interval design for dose finding in drug-combination trialsRuitao Lin, Guosheng YinBiostatistics (Oxford, England)|August 24, 2016
Nonparametric overdose control with late-onset toxicity in phase I clinical trialsRuitao Lin, Guosheng YinPharmaceutical Statistics|August 2, 2018
Uniformly most powerful Bayesian interval design for phase I dose-finding trialsRuitao Lin, Guosheng YinPageof 182